Dow HDPE DMDA-8940 HEALTH is a medium-molecular-weight high-density polyethylene resin manufactured for extrusion blow molding of healthcare packaging. The grade carries a nominal melt flow rate of 0.40 g/10 min when tested at 190 °C/2.16 kg according to ASTM D1238, and a nominal density of 0.954 g/cm³ according to ASTM D1505. The HEALTH designation identifies a regulatory packaging path rather than a different polymer backbone: the grade is supplied with documentation supporting pharmacopoeial and food-contact monographs, including USP <661.1>, Ph. Eur. 3.1.3, and FDA 21 CFR 177.1520. It is supplied as pellets in controlled-lot packaging; the manufacturer’s certificate of analysis typically reports melt flow rate, density, and relevant batch-specific compliance statements. The resin is intended for blow molded containers, closures, and bottle components used in solid oral dose, liquid oral care, and topical healthcare applications. It is not formulated for parenteral solution containers or implantable devices. The balance between the 0.40 g/10 min MFR and the 0.954 g/cm³ density provides parison melt strength sufficient for shallow to medium-depth extrusion blow molding tools, while retaining stiffness typical of HDPE. This opening section is not a specification; release limits are defined by the manufacturer’s product specification and regional regulatory submissions.

What Distinguishes the HEALTH Designation from General-Purpose HDPE Blow Molding Grades?

The distinction between DMDA-8940 HEALTH and a non-HEALTH HDPE blow molding grade of equivalent MFR and density is primarily evident in regulatory documentation, change control, and extractables screening. The HEALTH grade is evaluated against the physicochemical requirements of USP <661.1> for plastic packaging systems, including UV absorbance, pH, and reducing substances, and against the Ph. Eur. 3.1.3 monograph for polyolefins, which limits certain additives and sets migration-related acceptance criteria. Compliance with FDA 21 CFR 177.1520 is cited for food-contact use, and EU Regulation 10/2011 is typically referenced for articles intended for food contact in the European market. In contrast, a general-purpose blow molding HDPE may be certified only for tensile, density, and MFR without the pharmacopoeial extractables profile. This does not imply that the base polymer is chemically unique; rather, the HEALTH designation signals that the specific production campaign, additive package, and documentation have been selected and audited for healthcare packaging end uses. For drug product packaging, additional container closure system qualification remains necessary because the cited monographs do not replace product-specific stability or leachables studies.

Pellets of DMDA-8940 HEALTH are hydrophobic and do not require routine pre-drying when stored in dry, covered conditions. If sacks or octabins have been exposed to sustained relative humidity above 60 %, surface moisture can generate splay or surface defects in the parison; a pre-dry at 80 °C for 2 h in a desiccant hopper dryer is used to re-establish a consistent moisture level below 0.05 % by weight. Incoming material should be sampled for melt flow rate and density using the same test methods as the certificate of analysis, ISO 1133-1:2022 and ISO 1183-1, to detect any storage-induced or handling error before release to the extrusion blow molding cell. Re-ground cold runners and bottles may be blended with virgin material up to 20 wt%, subject to the healthcare packaging quality system; higher regrind ratios can shift melt viscosity and elevate the probability of black specks and gel defects. The use of regrind in pharmacopoeial articles must be validated by the packaging manufacturer against USP <661.1> and Ph. Eur. 3.1.3 criteria.

Property Profile Anchored to ASTM and ISO Methods

Table 1 reproduces representative physical and mechanical values from the manufacturer’s published technical data sheet. The values are not to be interpreted as release limits; lot-specific values are provided on the certificate of analysis. The melt flow rate of 0.40 g/10 min places the resin in the medium-molecular-weight HDPE blow molding range; this is lower than high-flow injection molding grades and supports parison hang strength during extrusion blow molding. Tensile yield strength and flexural modulus are reported by ASTM D638 and ASTM D790, respectively. Environmental stress crack resistance is a critical parameter for healthcare bottles, particularly when the filled product contains surfactants or alcohols at low concentrations. The ESCR test is conducted under ASTM D1693 condition B in 100 % Igepal CO-630; representative F50 values exceed 600 h. The density of 0.954 g/cm³ contributes to barrier and stiffness; however, it also reduces low-temperature impact compared with lower-density polyethylene copolymers. Therefore, applications requiring cold-chain storage below -20 °C should evaluate impact performance using ISO 179 or ASTM D256 on finished containers.

Finished container qualification for DMDA-8940 HEALTH typically includes top-load compression according to ASTM D2659, drop impact according to ASTM D2463 or ISTA 1A, and closure torque retention according to ASTM D3475 for continuous-thread or child-resistant closures. These tests are not intrinsic material properties; they are influenced by wall thickness distribution, tooling, and blow molding parameters. The resin does not guarantee a specific top-load value without a defined container geometry and process. Leak testing of molded bottles is commonly conducted according to ASTM D4991 using vacuum decay or dye penetration on a defined sampling plan.

When Extrusion Blow Molding Barrel Profiles and Parison Control Interact

Extrusion blow molding of DMDA-8940 HEALTH on production lines equipped with 60 mm to 90 mm single-screw extruders and 24:1 to 30:1 L/D barrier screws is typically performed with barrel temperatures from 180 °C to 220 °C. The die head and accumulator should be held at 170 °C to 200 °C to prevent premature parison sag. Mold temperatures between 10 °C and 30 °C are used to balance cycle time against surface gloss. Blow air pressure should be maintained at 0.4 MPa to 0.8 MPa; lower pressure yields incomplete replication of neck threads and embossed lettering, while higher pressure does not compensate for poor parison centering. The melt temperature threshold is process-critical: below 170 °C, high back pressure and melt fracture may appear, producing rough parison surfaces; above 230 °C, oxidative degradation accelerates, increasing odor and taste defects in the finished container. The processing window is wider than injection molding but not indefinite; residence time in the extruder and accumulator should be kept below 10 min for dark-color or high-shear dies. On single-cavity pharmaceutical bottle tools, cycle times typically range from 12 s to 30 s depending on part weight, wall thickness, and cooling water temperature. Parison programming is used for containers with non-uniform wall designs; the 0.40 g/10 min MFR provides sufficient melt strength to reduce sag in bottles up to 1 L capacity. For larger or multi-layer containers, a higher melt strength grade or coextrusion barrier layer may be required.

DMDA-8940 HEALTH is not recommended for continuous service above 60 °C because HDPE stiffness and ESCR decline with temperature; short excursions during hot filling should be validated on the finished container and should not exceed 75 °C for more than 30 min. The resin is incompatible with strong oxidizing acids, such as concentrated nitric or sulfuric acid, and with high concentrations of aromatic hydrocarbons and chlorinated solvents, especially at elevated temperature. Surfactant-based liquid formulations may stress-crack HDPE over time; this is assessed by bottle ESCR testing under ASTM D1693 on molded parts, not only on compression molded specimens. Additives used in masterbatch colorants should be screened for compatibility with pharmacopoeial extractables requirements; amine-based antistatic additives can elevate extractables and may interfere with USP <661.1> acceptance limits. If the packaging line uses silicone-based mold release or lubricant sprays, residues on finished containers must be removed or qualified, because they can alter surface chemistry and affect label adhesion and leachables profiles.

Regulatory Claims That Require Certificate-of-Analysis Verification

Table 2 lists the compliance references commonly cited for this grade. These references are not automatic declarations for every finished container; they require verification on the final packaged article, including labels, closures, and secondary packaging where applicable. A certificate of analysis does not replace product-specific stability testing for a new drug product or food contact application.

Compared with high-flow HDPE injection molding grades with MFR values above 10 g/10 min, DMDA-8940 HEALTH is poorly suited to thin-wall injection molding because the high viscosity of the 0.40 g/10 min melt lengthens fill times and increases clamp force requirements. Compared with lower-density polyethylene copolymers in the 0.930 g/cm³ to 0.940 g/cm³ range, the 0.954 g/cm³ density of DMDA-8940 HEALTH gives higher top-load strength and better moisture barrier, but lower low-temperature impact and ESCR. Within blow molding HDPE families, selection between DMDA-8940 HEALTH and a higher-MFR grade is determined by part weight, die swell, and parison length; larger bottles with long parison hang lengths generally require melt flow rates below 0.5 g/10 min, while small, intricate pharmaceutical containers may tolerate MFR up to 0.8 g/10 min. The HEALTH designation does not change these rheological selection rules; it adds the documentation and extractables screening required for regulated healthcare packaging. Published data for specific comparisons with every alternative Dow HDPE grade is limited; final material selection should be verified on production-scale extrusion blow molding equipment using the actual tooling, closure system, and line speed.